Stay updated on Hemay808 Clinical Trial: Phase I Study
Sign up to get notified when there's something new on the Hemay808 Clinical Trial: Phase I Study page.

Latest updates to the Hemay808 Clinical Trial: Phase I Study page
- CheckyesterdayChange DetectedThe record describes a completed Phase I study of topical Hemay808 in healthy adults, including its study design, eligibility criteria, treatment groups, and safety and pharmacokinetic outcomes.SummaryDifference46%

- Check8 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe page shows a 403 Forbidden message instead of study-record content, alongside a site-wide NIH announcement about terminology changes during the transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference2%

- Check22 days agoChange DetectedThe site revision number in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous content with a standard access-denied screen. This indicates the page content is currently inaccessible, with navigation and footer still visible on the error page.SummaryDifference18%

Stay in the know with updates to Hemay808 Clinical Trial: Phase I Study
Enter your email address, and we'll notify you when there's something new on the Hemay808 Clinical Trial: Phase I Study page.